Summary: Research into therapeutic uses of hallucinogens is expanding, but far less is known about the people who experiment with psychedelics recreationally. A recent study finds that self-described “psychonauts” behave differently from typical recreational users: they tend to document experiences rigorously, take a more methodical approach to dosing and risk, and show distinct personality and cognitive traits.
Source: The Conversation; study published in Frontiers in Psychiatry
There is a growing subculture of drug users who combine technical knowledge with careful self-experimentation. Known as “psychonauts” (literally “soul navigators”), these individuals — sometimes called cyber-psychonauts or e-psychonauts — use a wide range of hallucinogenic substances, both synthetic and natural, to pursue self-exploration, spiritual insight or altered states of consciousness. Unlike people who consume drugs mainly for socializing at parties, psychonauts often adopt a methodical, almost scientific approach to documenting and sharing their experiences online.
Because psychonauts are a relatively understudied group, their characteristics have been unclear. In our recent research published in Frontiers in Psychiatry, we examined how psychonauts differ from other users in personality, cognition and behavior.
Previous surveys and reviews suggest psychonauts are typically younger adults, often male, well educated and proficient with information technology. Many report heightened euphoria, empathy, creativity and alertness when using psychedelic substances — effects consistent with these drugs’ action on serotonin receptors in frontal brain regions that influence mood, perception and cognition. Some hallucinogens also have stimulant properties that can increase energy and focus.
Changing market
The landscape of hallucinogenic substances continues to shift rapidly. Novel psychoactive substances — compounds designed or marketed to mimic established drugs such as ecstasy, cannabis or amphetamines — have proliferated over the past decade. Often sold under changing names and ambiguous descriptions, these products created a cat-and-mouse dynamic between regulators and vendors. The so-called “legal highs” era led to policy responses aimed at broad bans on new psychoactive compounds, but new analogues and formulations keep appearing.
Retail closures and regulatory changes have pushed much of this trade online. The internet provides access to many products without the oversight typical of pharmaceutical manufacturing, and some listings carry disclaimers such as “not for human consumption.” At the same time, online forums and communities have become hubs where psychonauts document experiences, compare purity and dosage, and discuss safety considerations prior to experimentation. These anonymized spaces allow sharing of detailed, technical knowledge among like-minded peers.
Psychonaut profile
To better understand psychonauts, we assessed 82 participants divided into three groups: psychonauts, recreational “club drug” users who were seeking help for problematic use, and non-users. We examined personality traits and cognitive functioning, distinguishing between “cold” cognition (planning, attention, problem-solving) and “hot” cognition (emotion-driven decision-making and social-emotional processing).
Our findings indicate that psychonauts display intact “cold” cognitive abilities: they perform well on tasks requiring attention, planning and problem-solving. However, they differ from non-users in aspects of “hot” cognition: psychonauts show higher sensation-seeking and greater willingness to take risks. These traits suggest a drive toward novel or intense experiences rather than impaired cognitive control.
By contrast, the group of club drug users seeking treatment showed difficulties in “cold” cognition, particularly in learning and memory, along with problems controlling impulses. This pattern aligns with research on people dependent on stimulant drugs, who tend to struggle with both emotional decision-making and executive functions. For example, some individuals with stimulant dependence favor immediate smaller rewards over larger delayed ones, reflecting reduced impulse control and altered valuation of future outcomes.
The preserved cold cognition among psychonauts may help explain why many adopt cautious practices around dosing and substance selection. Because their primary motivation is to explore and fully experience the effects of hallucinogens while sharing detailed reports with peers, psychonauts often monitor dosage carefully and keep records that aim to minimize harm. In our sample, psychonauts were screened to exclude psychiatric illness and were actively engaged in employment or full-time education, suggesting a specific recreational user profile that integrates regular psychedelic use into a functional lifestyle.
Future research should track psychonauts and other user groups over time in longitudinal studies to determine whether observed cognitive and personality differences are pre-existing traits or consequences of drug exposure. Such work could reveal whether sensation-seeking tendencies intensify with prolonged engagement in online communities and repeated experimentation.
Meanwhile, clinical research into psychedelics continues in parallel. Compounds like psilocybin and ketamine are under investigation for treatment-resistant depression and other challenging psychiatric conditions, and specialized clinics offering psychedelic-assisted therapy have started to appear. Ongoing clinical trials aim to clarify therapeutic potential, mechanisms of action and safety profiles. Engaging responsibly with experienced psychonaut communities, both online and offline, may provide useful contextual insights to inform scientific study and harm-reduction efforts.
Funding:
Barbara Jacquelyn Sahakian receives research support from several charitable foundations and institutions. Her work is conducted within university-affiliated biomedical research centres and she provides consultancy services to a cognitive assessment company. George Savulich reports no commercial conflicts of interest and has no affiliations beyond his academic appointment.
About this psychology research news
Source: The Conversation
Contact: George Savulich and Barbara Jacquelyn Sahakian – The Conversation
Image: The image is in the public domain